| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.957 | 0.002 | 0.97 | Aldehyde oxidase inhibitor | 0.803 0.004 CID_104607 0.97 0.002 CID_158069 0.871 0.004 CID_1527023 | CID_158069 | |
| 0.743 | 0.003 | 0.743 | Dopamine D4 antagonist | 0.209 0.012 CID_104607 0.589 0.004 CID_158069 0.179 0.014 CID_1527023 | ||
| 0.705 | 0.004 | 0.705 | Dopamine antagonist | 0.253 0.014 CID_104607 0.67 0.004 CID_158069 0.24 0.015 CID_1527023 | ||
| 0.679 | 0.004 | 0.679 | 5 Hydroxytryptamine antagonist | 0.364 0.013 CID_104607 0.472 0.008 CID_158069 0.282 0.021 CID_1527023 | ||
| 0.678 | 0.004 | 0.678 | Alpha adrenoreceptor antagonist | 0.34 0.013 CID_104607 0.636 0.004 CID_158069 0.246 0.021 CID_1527023 | ||
| 0.658 | 0.004 | 0.658 | Alpha 1 adrenoreceptor antagonist | 0.303 0.011 CID_104607 0.614 0.004 CID_158069 0.186 0.023 CID_1527023 | ||
| 0.642 | 0.004 | 0.642 | Dopamine D2 antagonist | 0.22 0.015 CID_104607 0.613 0.004 CID_158069 0.224 0.015 CID_1527023 | ||
| 0.624 | 0.004 | 0.624 | Alpha 1a adrenoreceptor antagonist | 0.279 0.01 CID_104607 0.563 0.004 CID_158069 0.159 0.022 CID_1527023 | ||
| 0.582 | 0.003 | 0.582 | Alpha 1b adrenoreceptor antagonist | 0.25 0.01 CID_104607 0.546 0.004 CID_158069 0.204 0.014 CID_1527023 | ||
| 0.569 | 0.003 | 0.587 | Acetylcholine agonist | 0.587 0.003 CID_104607 0.383 0.004 CID_158069 0.189 0.016 CID_1527023 | CID_104607 | |
| 0.558 | 0.009 | 0.558 | Anticonvulsant | 0.382 0.024 CID_104607 0.286 0.044 CID_158069 0.424 0.019 CID_1527023 | ||
| 0.541 | 0.005 | 0.541 | 5 Hydroxytryptamine 2 antagonist | 0.279 0.018 CID_104607 0.397 0.01 CID_158069 0.252 0.021 CID_1527023 | ||
| 0.516 | 0.005 | 0.516 | 5 Hydroxytryptamine 2B antagonist | 0.3 0.014 CID_104607 0.409 0.008 CID_158069 0.276 0.016 CID_1527023 | ||
| 0.5 | 0.002 | 0.5 | Acetylcholine muscarinic agonist | 0.487 0.002 CID_104607 0.322 0.004 CID_158069 0.198 0.006 CID_1527023 | ||
| 0.5 | 0.003 | 0.5 | 5 Hydroxytryptamine 3 antagonist | 0.425 0.003 CID_104607 0.234 0.005 CID_158069 0.215 0.005 CID_1527023 | ||
| 0.511 | 0.025 | 0.677 | Histamine release inhibitor | 0.317 0.115 CID_104607 0.544 0.017 CID_158069 0.677 0.005 CID_1527023 | CID_1527023 | |
| 0.469 | 0.002 | 0.48 | Acetylcholine M1 receptor agonist | 0.48 0.002 CID_104607 0.274 0.004 CID_158069 0.162 0.006 CID_1527023 | CID_104607 | |
| 0.466 | 0.005 | 0.466 | 5 Hydroxytryptamine 2A antagonist | 0.203 0.019 CID_104607 0.324 0.01 CID_158069 0.187 0.021 CID_1527023 | ||
| 0.463 | 0.005 | 0.463 | 5 Hydroxytryptamine 1A antagonist | 0.173 0.017 CID_104607 0.35 0.007 CID_158069 0.22 0.013 CID_1527023 | ||
| 0.496 | 0.05 | 0.512 | Analgesic | 0.512 0.046 CID_104607 0.419 0.076 CID_158069 | CID_104607 | |
| 0.443 | 0.005 | 0.443 | Antihistaminic | 0.164 0.028 CID_104607 0.188 0.023 CID_158069 0.133 0.037 CID_1527023 | ||
| 0.44 | 0.002 | 0.44 | 5 Hydroxytryptamine 3B antagonist | 0.204 0.003 CID_104607 0.17 0.004 CID_158069 0.205 0.003 CID_1527023 | ||
| 0.439 | 0.004 | 0.439 | 5 Hydroxytryptamine 1E antagonist | 0.435 0.004 CID_104607 0.394 0.005 CID_158069 0.319 0.019 CID_1527023 | ||
| 0.439 | 0.005 | 0.439 | 5 Hydroxytryptamine 7 antagonist | 0.213 0.011 CID_104607 0.281 0.006 CID_158069 0.29 0.006 CID_1527023 | ||
| 0.437 | 0.004 | 0.437 | Dopamine D3 antagonist | 0.16 0.014 CID_104607 0.357 0.005 CID_158069 0.184 0.012 CID_1527023 | ||
| 0.434 | 0.005 | 0.434 | Histamine antagonist | 0.155 0.028 CID_104607 0.169 0.025 CID_158069 0.121 0.038 CID_1527023 | ||
| 0.426 | 0.003 | 0.426 | Nociceptin (N/OFQ) receptor antagonist | 0.401 0.003 CID_104607 0.313 0.003 CID_158069 0.119 0.005 CID_1527023 | ||
| 0.426 | 0.004 | 0.426 | Alpha 1d adrenoreceptor antagonist | 0.143 0.015 CID_104607 0.37 0.004 CID_158069 0.164 0.013 CID_1527023 | ||
| 0.426 | 0.005 | 0.426 | 5 Hydroxytryptamine 1 antagonist | 0.151 0.023 CID_104607 0.292 0.01 CID_158069 0.219 0.015 CID_1527023 | ||
| 0.41 | 0.002 | 0.41 | 5 Hydroxytryptamine 3A antagonist | 0.31 0.003 CID_104607 0.208 0.004 CID_158069 0.219 0.004 CID_1527023 | ||
| 0.409 | 0.004 | 0.409 | Histamine H1 receptor antagonist | 0.145 0.026 CID_104607 0.236 0.011 CID_158069 0.145 0.026 CID_1527023 | ||
| 0.398 | 0.005 | 0.398 | 5 Hydroxytryptamine 2C antagonist | 0.265 0.011 CID_104607 0.267 0.011 CID_158069 0.152 0.026 CID_1527023 | ||
| 0.385 | 0.004 | 0.496 | Dopamine D1 antagonist | 0.172 0.013 CID_104607 0.496 0.003 CID_158069 0.141 0.016 CID_1527023 | CID_158069 | |
| 0.405 | 0.027 | 0.405 | HERG channel blocker | 0.403 0.027 CID_104607 0.226 0.076 CID_158069 | ||
| 0.371 | 0.002 | 0.427 | 5 Hydroxytryptamine 3A agonist | 0.427 0.002 CID_104607 0.33 0.003 CID_158069 0.231 0.008 CID_1527023 | CID_104607 | |
| 0.392 | 0.023 | 0.392 | Sigma receptor agonist | 0.124 0.109 CID_104607 0.377 0.025 CID_158069 | ||
| 0.378 | 0.009 | 0.378 | Antiadrenergic | 0.158 0.034 CID_104607 0.327 0.012 CID_158069 0.235 0.019 CID_1527023 | ||
| 0.375 | 0.009 | 0.375 | Adrenaline antagonist | 0.155 0.033 CID_104607 0.326 0.012 CID_158069 0.233 0.019 CID_1527023 | ||
| 0.369 | 0.012 | 0.421 | Cholinergic | 0.421 0.009 CID_104607 0.294 0.019 CID_158069 | CID_104607 | |
| 0.345 | 0.009 | 0.345 | Acetylcholine M1 receptor antagonist | 0.305 0.014 CID_104607 0.318 0.012 CID_158069 0.223 0.033 CID_1527023 | ||
| 0.34 | 0.004 | 0.34 | Alpha 1 adrenoreceptor agonist | 0.127 0.012 CID_104607 0.315 0.004 CID_158069 0.17 0.008 CID_1527023 | ||
| 0.32 | 0.002 | 0.32 | Acetylcholine M4 receptor agonist | 0.212 0.002 CID_104607 0.127 0.003 CID_158069 0.119 0.004 CID_1527023 | ||
| 0.324 | 0.007 | 0.324 | Nav1.1 sodium channel blocker | 0.264 0.011 CID_104607 0.29 0.009 CID_158069 0.201 0.019 CID_1527023 | ||
| 0.316 | 0.005 | 0.316 | Toll-Like receptor antagonist | 0.276 0.01 CID_104607 0.314 0.006 CID_158069 0.197 0.032 CID_1527023 | ||
| 0.335 | 0.03 | 0.62 | Cyclic AMP phosphodiesterase inhibitor | 0.216 0.082 CID_104607 0.337 0.029 CID_158069 0.62 0.004 CID_1527023 | CID_1527023 | |
| 0.334 | 0.04 | 0.334 | Potassium channel (Voltage-sensitive) blocker | 0.331 0.041 CID_104607 0.186 0.106 CID_158069 | ||
| 0.299 | 0.006 | 0.299 | Alpha 2c adrenoreceptor antagonist | 0.176 0.023 CID_104607 0.266 0.008 CID_158069 0.209 0.016 CID_1527023 | ||
| 0.296 | 0.009 | 0.296 | Alpha 2b adrenoreceptor antagonist | 0.201 0.024 CID_104607 0.265 0.012 CID_158069 0.232 0.017 CID_1527023 | ||
| 0.286 | 0.016 | 0.286 | Nav1.2 sodium channel blocker | 0.212 0.03 CID_104607 0.206 0.032 CID_158069 0.142 0.062 CID_1527023 | ||
| 0.266 | 0.002 | 0.266 | 5 Hydroxytryptamine 4 antagonist | 0.122 0.004 CID_104607 0.183 0.003 CID_158069 0.159 0.003 CID_1527023 | ||
| 0.283 | 0.025 | 0.292 | Diuretic | 0.292 0.024 CID_104607 0.203 0.043 CID_158069 0.239 0.033 CID_1527023 | CID_104607 | |
| 0.254 | 0.003 | 0.324 | Acetylcholine M3 receptor agonist | 0.324 0.002 CID_104607 0.225 0.003 CID_158069 0.167 0.012 CID_1527023 | CID_104607 | |
| 0.236 | 0.007 | 0.434 | Dopamine agonist | 0.109 0.024 CID_104607 0.237 0.007 CID_158069 0.434 0.005 CID_1527023 | CID_1527023 | |
| 0.236 | 0.01 | 0.351 | NMDA receptor antagonist | 0.185 0.017 CID_104607 0.351 0.005 CID_158069 0.148 0.025 CID_1527023 | CID_158069 | |
| 0.229 | 0.007 | 0.229 | Alpha adrenoreceptor agonist | 0.165 0.014 CID_104607 0.221 0.007 CID_158069 0.211 0.008 CID_1527023 | ||
| 0.22 | 0.002 | 0.233 | Acetylcholine M5 receptor agonist | 0.233 0.002 CID_104607 0.17 0.004 CID_158069 0.129 0.008 CID_1527023 | CID_104607 | |
| 0.221 | 0.003 | 0.302 | Acetylcholine M2 receptor agonist | 0.302 0.003 CID_104607 0.162 0.004 CID_158069 0.073 0.017 CID_1527023 | CID_104607 | |
| 0.208 | 0.005 | 0.208 | Dopamine D5 antagonist | 0.075 0.013 CID_104607 0.187 0.005 CID_158069 0.144 0.007 CID_1527023 | ||
| 0.215 | 0.015 | 0.215 | Alpha 2 adrenoreceptor antagonist | 0.154 0.026 CID_104607 0.187 0.02 CID_158069 0.162 0.024 CID_1527023 | ||
| 0.198 | 0.001 | 0.209 | Phospholipase D inhibitor | 0.209 0.001 CID_104607 0.175 0.002 CID_158069 0.145 0.004 CID_1527023 | CID_104607 | |
| 0.2 | 0.007 | 0.2 | Dopamine D4 agonist | 0.098 0.015 CID_104607 0.104 0.014 CID_158069 0.069 0.023 CID_1527023 | ||
| 0.197 | 0.006 | 0.197 | Acetylcholine M4 receptor antagonist | 0.17 0.008 CID_104607 0.106 0.024 CID_158069 0.1 0.028 CID_1527023 | ||
| 0.195 | 0.01 | 0.245 | 5 Hydroxytryptamine 1F antagonist | 0.146 0.017 CID_104607 0.126 0.022 CID_158069 0.245 0.008 CID_1527023 | CID_1527023 | |
| 0.24 | 0.056 | 0.432 | RNA-directed DNA polymerase inhibitor | 0.254 0.047 CID_104607 0.265 0.042 CID_158069 0.432 0.015 CID_1527023 | CID_1527023 | |
| 0.204 | 0.023 | 0.204 | Acetylcholine muscarinic antagonist | 0.176 0.032 CID_104607 0.177 0.031 CID_158069 0.127 0.061 CID_1527023 | ||
| 0.18 | 0.002 | 0.18 | Calcitonin gene-related peptide 1 receptor antagonist | 0.171 0.002 CID_104607 0.138 0.003 CID_158069 0.118 0.003 CID_1527023 | ||
| 0.2 | 0.036 | 0.2 | Toll-Like receptor 9 antagonist | 0.122 0.084 CID_104607 0.177 0.047 CID_158069 0.172 0.049 CID_1527023 | ||
| 0.161 | 0.002 | 0.163 | Calcitonin gene-related peptide antagonist | 0.163 0.002 CID_104607 0.106 0.003 CID_158069 0.077 0.004 CID_1527023 | CID_104607 | |
| 0.158 | 0.003 | 0.173 | Nociceptin (N/OFQ) receptor agonist | 0.173 0.003 CID_104607 0.129 0.003 CID_158069 0.035 0.009 CID_1527023 | CID_104607 | |
| 0.245 | 0.094 | 0.266 | Spasmolytic | 0.177 0.139 CID_104607 0.266 0.085 CID_158069 0.252 0.09 CID_1527023 | CID_158069 | |
| 0.18 | 0.03 | 0.18 | Neuropeptide Y1 antagonist | 0.161 0.049 CID_104607 0.175 0.034 CID_158069 0.153 0.061 CID_1527023 | ||
| 0.16 | 0.012 | 0.16 | 5 Hydroxytryptamine 1B antagonist | 0.094 0.026 CID_104607 0.088 0.029 CID_158069 0.136 0.014 CID_1527023 | ||
| 0.153 | 0.005 | 0.291 | 5 Hydroxytryptamine 3 agonist | 0.291 0.003 CID_104607 0.121 0.009 CID_158069 0.081 0.026 CID_1527023 | CID_104607 | |
| 0.149 | 0.003 | 0.149 | CC chemokine 4 receptor antagonist | 0.129 0.004 CID_104607 0.12 0.004 CID_158069 0.083 0.006 CID_1527023 | ||
| 0.164 | 0.02 | 0.209 | DNA directed RNA polymerase inhibitor | 0.146 0.025 CID_104607 0.13 0.031 CID_158069 0.209 0.013 CID_1527023 | CID_1527023 | |
| 0.163 | 0.02 | 0.163 | Alpha 2a adrenoreceptor antagonist | 0.146 0.023 CID_104607 0.155 0.021 CID_158069 0.118 0.03 CID_1527023 | ||
| 0.158 | 0.015 | 0.252 | NMDA 2 receptor antagonist | 0.101 0.031 CID_104607 0.252 0.006 CID_158069 0.146 0.017 CID_1527023 | CID_158069 | |
| 0.149 | 0.008 | 0.149 | Acetylcholine M5 receptor antagonist | 0.115 0.014 CID_104607 0.105 0.016 CID_158069 0.073 0.028 CID_1527023 | ||
| 0.161 | 0.023 | 0.182 | Opioid antagonist | 0.156 0.024 CID_104607 0.182 0.018 CID_158069 | CID_158069 | |
| 0.173 | 0.041 | 0.181 | Cholinergic antagonist | 0.181 0.038 CID_104607 0.151 0.052 CID_158069 0.107 0.087 CID_1527023 | CID_104607 | |
| 0.243 | 0.113 | 0.276 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.276 0.083 CID_104607 0.245 0.111 CID_158069 | CID_104607 | |
| 0.135 | 0.008 | 0.178 | Toll-Like receptor 7 antagonist | 0.178 0.005 CID_104607 0.103 0.019 CID_158069 0.074 0.043 CID_1527023 | CID_104607 | |
| 0.167 | 0.042 | 0.175 | Acetylcholine antagonist | 0.175 0.038 CID_104607 0.145 0.053 CID_158069 0.104 0.087 CID_1527023 | CID_104607 | |
| 0.145 | 0.023 | 0.211 | 5 Hydroxytryptamine agonist | 0.211 0.013 CID_104607 0.064 0.051 CID_158069 0.082 0.041 CID_1527023 | CID_104607 | |
| 0.152 | 0.031 | 0.152 | Chemokine receptor antagonist | 0.133 0.04 CID_104607 0.104 0.059 CID_158069 | ||
| 0.127 | 0.008 | 0.371 | Dopamine D2 agonist | 0.041 0.033 CID_104607 0.151 0.006 CID_158069 0.371 0.004 CID_1527023 | CID_1527023 | |
| 0.134 | 0.015 | 0.189 | Bromodomain-containing protein 2 inhibitor | 0.189 0.004 CID_104607 0.098 0.043 CID_158069 0.097 0.044 CID_1527023 | CID_104607 | |
| 0.258 | 0.141 | 0.416 | Toll-Like receptor 7 agonist | 0.227 0.17 CID_158069 0.416 0.053 CID_1527023 | CID_1527023 | |
| 0.158 | 0.043 | 0.158 | Nav1.3 sodium channel blocker | 0.109 0.087 CID_104607 0.133 0.061 CID_1527023 | ||
| 0.259 | 0.148 | 0.447 | Antiobesity | 0.447 0.05 CID_104607 0.213 0.194 CID_158069 | CID_104607 | |
| 0.2 | 0.09 | 0.336 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.336 0.028 CID_104607 0.166 0.123 CID_158069 | CID_104607 | |
| 0.112 | 0.005 | 0.119 | MDM2 inhibitor | 0.119 0.004 CID_104607 0.089 0.012 CID_158069 0.079 0.021 CID_1527023 | CID_104607 | |
| 0.144 | 0.038 | 0.191 | Interleukin 8 antagonist | 0.191 0.015 CID_104607 0.161 0.028 CID_158069 0.106 0.083 CID_1527023 | CID_104607 | |
| 0.241 | 0.135 | 0.474 | Vasodilator, peripheral | 0.361 0.069 CID_104607 0.226 0.148 CID_158069 0.474 0.034 CID_1527023 | CID_1527023 | |
| 0.191 | 0.085 | 0.235 | Psychostimulant | 0.235 0.064 CID_104607 0.183 0.091 CID_158069 0.193 0.084 CID_1527023 | CID_104607 | |
| 0.251 | 0.147 | 0.427 | Toll-Like receptor agonist | 0.221 0.178 CID_158069 0.427 0.05 CID_1527023 | CID_1527023 | |
| 0.112 | 0.009 | 0.112 | Neurokinin 2 antagonist | 0.111 0.009 CID_104607 0.059 0.02 CID_158069 | ||
| 0.146 | 0.044 | 0.146 | MAP kinase 12 inhibitor | 0.141 0.048 CID_104607 0.12 0.07 CID_158069 0.12 0.07 CID_1527023 | ||
| 0.122 | 0.021 | 0.221 | HIV-1 reverse transcriptase inhibitor | 0.099 0.031 CID_104607 0.104 0.029 CID_158069 0.221 0.008 CID_1527023 | CID_1527023 | |
| 0.121 | 0.025 | 0.198 | Protein kinase B gamma inhibitor | 0.198 0.008 CID_104607 0.074 0.052 CID_158069 | CID_104607 | |
| 0.108 | 0.012 | 0.143 | Opioid agonist | 0.143 0.008 CID_104607 0.117 0.01 CID_158069 | CID_104607 | |
| 0.105 | 0.01 | 0.124 | Phosphodiesterase VII inhibitor | 0.124 0.005 CID_104607 0.087 0.02 CID_158069 0.092 0.017 CID_1527023 | CID_104607 | |
| 0.116 | 0.025 | 0.142 | Opioid kappa receptor antagonist | 0.116 0.025 CID_104607 0.142 0.018 CID_158069 | CID_158069 | |
| 0.118 | 0.03 | 0.118 | Neuropeptide Y antagonist | 0.109 0.035 CID_104607 0.078 0.062 CID_158069 | ||
| 0.099 | 0.013 | 0.107 | Antidiuretic hormone antagonist | 0.107 0.011 CID_104607 0.055 0.021 CID_158069 | CID_104607 | |
| 0.101 | 0.016 | 0.107 | Calcium channel T-type blocker | 0.066 0.031 CID_104607 0.107 0.014 CID_1527023 | CID_1527023 | |
| 0.112 | 0.029 | 0.112 | CC chemokine receptor antagonist | 0.092 0.041 CID_104607 0.074 0.057 CID_158069 | ||
| 0.107 | 0.025 | 0.133 | Nicotinic alpha4beta2 receptor antagonist | 0.133 0.012 CID_104607 0.073 0.058 CID_158069 0.094 0.037 CID_1527023 | CID_104607 | |
| 0.163 | 0.081 | 0.244 | ATPase inhibitor | 0.172 0.069 CID_158069 0.244 0.015 CID_1527023 | CID_1527023 | |
| 0.288 | 0.208 | 0.402 | Caspase 9 stimulant | 0.291 0.204 CID_104607 0.369 0.131 CID_158069 0.402 0.11 CID_1527023 | CID_1527023 | |
| 0.084 | 0.008 | 0.096 | Sodium/calcium exchanger inhibitor | 0.096 0.005 CID_104607 0.067 0.014 CID_158069 0.087 0.007 CID_1527023 | CID_104607 | |
| 0.168 | 0.091 | 0.179 | MAP kinase kinase 5 inhibitor | 0.163 0.106 CID_104607 0.168 0.09 CID_158069 0.179 0.065 CID_1527023 | CID_1527023 | |
| 0.089 | 0.014 | 0.089 | Histamine H3 receptor antagonist | 0.041 0.033 CID_104607 | ||
| 0.077 | 0.003 | 0.077 | 5 Hydroxytryptamine 4 agonist | 0.037 0.004 CID_104607 0.037 0.004 CID_158069 0.049 0.004 CID_1527023 | ||
| 0.111 | 0.037 | 0.117 | Histamine N-methyltransferase inhibitor | 0.076 0.072 CID_104607 0.087 0.059 CID_158069 0.117 0.031 CID_1527023 | CID_1527023 | |
| 0.095 | 0.023 | 0.095 | Acetylcholine M2 receptor antagonist | 0.073 0.034 CID_104607 0.073 0.034 CID_158069 0.066 0.04 CID_1527023 | ||
| 0.085 | 0.013 | 0.085 | CC chemokine 3 receptor antagonist | 0.061 0.019 CID_104607 | ||
| 0.094 | 0.022 | 0.094 | 5 Hydroxytryptamine 1 agonist | 0.081 0.025 CID_1527023 | ||
| 0.074 | 0.009 | 0.083 | Phosphodiesterase 7A inhibitor | 0.083 0.005 CID_104607 0.065 0.015 CID_158069 0.068 0.013 CID_1527023 | CID_104607 | |
| 0.13 | 0.065 | 0.156 | Glutamate receptor antagonist | 0.156 0.047 CID_104607 0.123 0.071 CID_158069 0.118 0.076 CID_1527023 | CID_104607 | |
| 0.104 | 0.04 | 0.205 | Phosphodiesterase I inhibitor | 0.107 0.036 CID_104607 0.091 0.057 CID_158069 0.205 0.01 CID_1527023 | CID_1527023 | |
| 0.195 | 0.131 | 0.268 | DNA synthesis inhibitor | 0.257 0.062 CID_104607 0.21 0.109 CID_158069 0.268 0.056 CID_1527023 | CID_1527023 | |
| 0.081 | 0.019 | 0.081 | 5 Hydroxytryptamine 1A agonist | 0.042 0.036 CID_158069 0.081 0.019 CID_1527023 | ||
| 0.174 | 0.112 | 0.174 | Potassium channel blocker | 0.166 0.119 CID_104607 | ||
| 0.11 | 0.05 | 0.11 | Insulin receptor antagonist | 0.097 0.066 CID_104607 0.088 0.08 CID_158069 | ||
| 0.066 | 0.01 | 0.154 | Kainate receptor 2 antagonist | 0.057 0.013 CID_104607 0.033 0.028 CID_158069 0.154 0.003 CID_1527023 | CID_1527023 | |
| 0.089 | 0.033 | 0.131 | Protein kinase B beta inhibitor | 0.131 0.011 CID_104607 | CID_104607 | |
| 0.191 | 0.137 | 0.222 | Neuropeptide Y2 antagonist | 0.222 0.085 CID_104607 0.202 0.115 CID_1527023 | CID_104607 | |
| 0.115 | 0.061 | 0.13 | MAP kinase 13 inhibitor | 0.13 0.048 CID_104607 | CID_104607 | |
| 0.122 | 0.069 | 0.155 | DNA repair enzyme inhibitor | 0.155 0.027 CID_104607 0.123 0.066 CID_158069 0.15 0.031 CID_1527023 | CID_104607 | |
| 0.083 | 0.033 | 0.104 | 5 Hydroxytryptamine uptake inhibitor | 0.104 0.025 CID_104607 | CID_104607 | |
| 0.078 | 0.028 | 0.121 | Adrenaline uptake inhibitor | 0.121 0.014 CID_104607 0.056 0.05 CID_158069 | CID_104607 | |
| 0.079 | 0.032 | 0.136 | 5 Hydroxytryptamine 1D antagonist | 0.056 0.053 CID_104607 0.136 0.014 CID_1527023 | CID_1527023 | |
| 0.085 | 0.038 | 0.113 | Opioid mu receptor antagonist | 0.093 0.034 CID_104607 0.113 0.027 CID_158069 | CID_158069 | |
| 0.064 | 0.017 | 0.072 | Neurokinin 3 antagonist | 0.072 0.012 CID_104607 0.043 0.033 CID_158069 | CID_104607 | |
| 0.071 | 0.023 | 0.071 | Melanin-concentrating hormone receptor 1 antagonist | 0.06 0.03 CID_104607 | ||
| 0.06 | 0.014 | 0.135 | Glutamate (mGluR4) antagonist | 0.053 0.018 CID_104607 0.04 0.037 CID_158069 0.135 0.004 CID_1527023 | CID_1527023 | |
| 0.099 | 0.052 | 0.187 | Protein kinase C zeta inhibitor | 0.187 0.013 CID_104607 0.119 0.033 CID_158069 0.089 0.068 CID_1527023 | CID_104607 | |
| 0.06 | 0.014 | 0.168 | Dopamine D3 agonist | 0.058 0.015 CID_158069 0.168 0.004 CID_1527023 | CID_1527023 | |
| 0.069 | 0.024 | 0.16 | Toll-Like receptor 8 antagonist | 0.16 0.004 CID_104607 | CID_104607 | |
| 0.068 | 0.024 | 0.068 | Sigma receptor antagonist | 0.052 0.033 CID_158069 | ||
| 0.089 | 0.046 | 0.14 | Acetylcholine nicotinic agonist | 0.14 0.02 CID_104607 | CID_104607 | |
| 0.069 | 0.026 | 0.098 | NMDA 2B receptor antagonist | 0.098 0.016 CID_158069 0.081 0.021 CID_1527023 | CID_158069 | |
| 0.057 | 0.015 | 0.072 | Thymidine kinase inhibitor | 0.04 0.03 CID_104607 0.042 0.027 CID_158069 0.072 0.01 CID_1527023 | CID_1527023 | |
| 0.099 | 0.058 | 0.149 | Phosphodiesterase 7B inhibitor | 0.149 0.022 CID_104607 0.121 0.037 CID_1527023 | CID_104607 | |
| 0.052 | 0.013 | 0.052 | p53 inhibitor | 0.041 0.019 CID_104607 0.035 0.025 CID_158069 | ||
| 0.068 | 0.031 | 0.088 | Corticotropin releasing factor 2 receptor antagonist | 0.084 0.014 CID_104607 0.088 0.011 CID_1527023 | CID_1527023 | |
| 0.096 | 0.061 | 0.143 | Phosphodiesterase 6D inhibitor | 0.097 0.058 CID_158069 0.143 0.012 CID_1527023 | CID_1527023 | |
| 0.055 | 0.02 | 0.069 | Poly(ADP-ribose) polymerase inhibitor | 0.053 0.021 CID_104607 0.069 0.013 CID_1527023 | CID_1527023 | |
| 0.068 | 0.035 | 0.093 | NMDA 2C receptor antagonist | 0.093 0.018 CID_104607 0.083 0.023 CID_158069 0.081 0.024 CID_1527023 | CID_104607 | |
| 0.066 | 0.033 | 0.071 | Dopamine uptake inhibitor | 0.071 0.029 CID_104607 | CID_104607 | |
| 0.044 | 0.012 | 0.044 | CXC chemokine 3 receptor antagonist | 0.033 0.019 CID_104607 | ||
| 0.041 | 0.01 | 0.053 | Adenosine uptake inhibitor | 0.034 0.027 CID_104607 0.034 0.026 CID_158069 0.053 0.004 CID_1527023 | CID_1527023 | |
| 0.064 | 0.033 | 0.114 | 5 Hydroxytryptamine 6 antagonist | 0.114 0.011 CID_104607 | CID_104607 | |
| 0.051 | 0.02 | 0.153 | Kainate receptor antagonist | 0.048 0.023 CID_104607 0.153 0.005 CID_1527023 | CID_1527023 | |
| 0.043 | 0.012 | 0.043 | Sigma 2 receptor antagonist | 0.026 0.019 CID_158069 | ||
| 0.065 | 0.035 | 0.069 | Acetylcholine M3 receptor antagonist | 0.059 0.043 CID_104607 0.069 0.033 CID_158069 | CID_158069 | |
| 0.079 | 0.049 | 0.091 | Analgesic, opioid | 0.082 0.046 CID_104607 0.091 0.037 CID_158069 | CID_158069 | |
| 0.105 | 0.077 | 0.119 | Calcium channel (voltage-sensitive) blocker | 0.119 0.058 CID_1527023 | CID_1527023 | |
| 0.056 | 0.028 | 0.077 | Neurokinin antagonist | 0.077 0.017 CID_104607 | CID_104607 | |
| 0.044 | 0.016 | 0.06 | Vasopressin 1 antagonist | 0.06 0.013 CID_104607 0.029 0.026 CID_158069 | CID_104607 | |
| 0.041 | 0.015 | 0.064 | Vasopressin 1A antagonist | 0.064 0.01 CID_104607 | CID_104607 | |
| 0.058 | 0.031 | 0.089 | NMDA 2A receptor antagonist | 0.066 0.026 CID_104607 0.07 0.024 CID_158069 0.089 0.016 CID_1527023 | CID_1527023 | |
| 0.053 | 0.027 | 0.075 | Opioid mu receptor agonist | 0.075 0.019 CID_104607 0.072 0.02 CID_158069 | CID_104607 | |
| 0.128 | 0.102 | 0.154 | NOS3 expression enhancer | 0.154 0.068 CID_158069 | CID_158069 | |
| 0.034 | 0.009 | 0.047 | DNA polymerase III inhibitor | 0.03 0.016 CID_158069 0.047 0.004 CID_1527023 | CID_1527023 | |
| 0.086 | 0.061 | 0.128 | Interleukin 5 antagonist | 0.081 0.071 CID_104607 0.092 0.052 CID_158069 0.128 0.019 CID_1527023 | CID_1527023 | |
| 0.034 | 0.009 | 0.105 | Kainate receptor 1 antagonist | 0.027 0.011 CID_104607 0.105 0.004 CID_1527023 | CID_1527023 | |
| 0.029 | 0.005 | 0.128 | Somatostatin 2 agonist | 0.128 0.003 CID_104607 0.025 0.005 CID_158069 | CID_104607 | |
| 0.055 | 0.031 | 0.055 | CC chemokine 5 receptor antagonist | |||
| 0.081 | 0.057 | 0.081 | Phosphodiesterase 11A inhibitor | 0.081 0.057 CID_104607 | ||
| 0.081 | 0.057 | 0.081 | Phosphodiesterase XI inhibitor | 0.081 0.057 CID_104607 | ||
| 0.034 | 0.011 | 0.039 | CC chemokine 1 receptor antagonist | 0.039 0.009 CID_158069 | CID_158069 | |
| 0.071 | 0.051 | 0.084 | Calcium channel L-type blocker | 0.084 0.035 CID_1527023 | CID_1527023 | |
| 0.03 | 0.011 | 0.037 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.026 0.02 CID_104607 0.037 0.006 CID_1527023 | CID_1527023 | |
| 0.061 | 0.042 | 0.082 | 5 Hydroxytryptamine 5A antagonist | 0.082 0.022 CID_104607 0.069 0.032 CID_1527023 | CID_104607 | |
| 0.114 | 0.095 | 0.142 | Calcium channel blocker | 0.142 0.066 CID_1527023 | CID_1527023 | |
| 0.272 | 0.253 | 0.443 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.335 0.168 CID_104607 0.443 0.066 CID_1527023 | CID_1527023 | |
| 0.043 | 0.025 | 0.061 | Neurokinin 1 antagonist | 0.061 0.014 CID_104607 | CID_104607 | |
| 0.029 | 0.014 | 0.101 | Dopamine autoreceptor agonist | 0.043 0.009 CID_158069 0.101 0.004 CID_1527023 | CID_1527023 | |
| 0.077 | 0.062 | 0.131 | Adrenaline agonist | 0.131 0.021 CID_158069 0.112 0.03 CID_1527023 | CID_158069 | |
| 0.034 | 0.02 | 0.034 | Vanilloid 4 antagonist | |||
| 0.031 | 0.017 | 0.031 | Sigma 1 receptor antagonist | |||
| 0.117 | 0.104 | 0.178 | Sphingosine 1-phosphate receptor 2 antagonist | 0.117 0.105 CID_104607 0.118 0.101 CID_158069 0.178 0.016 CID_1527023 | CID_1527023 | |
| 0.023 | 0.009 | 0.028 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.022 0.012 CID_104607 0.028 0.005 CID_1527023 | CID_1527023 | |
| 0.043 | 0.03 | 0.049 | Opioid kappa receptor agonist | 0.044 0.029 CID_104607 0.049 0.025 CID_158069 | CID_158069 | |
| 0.039 | 0.028 | 0.044 | Substance P antagonist | 0.044 0.022 CID_104607 | CID_104607 | |
| 0.048 | 0.037 | 0.068 | Bromodomain-containing protein 3 inhibitor | 0.068 0.014 CID_104607 | CID_104607 | |
| 0.047 | 0.039 | 0.049 | CC chemokine receptor 2B antagonist | 0.049 0.033 CID_104607 | CID_104607 | |
| 0.036 | 0.029 | 0.044 | Poly(ADP-ribose) polymerase 1 inhibitor | 0.039 0.024 CID_104607 0.044 0.02 CID_1527023 | CID_1527023 | |
| 0.026 | 0.019 | 0.037 | Thymidine phosphorylase inhibitor | 0.028 0.015 CID_104607 0.037 0.008 CID_1527023 | CID_1527023 | |
| 0.044 | 0.038 | 0.125 | AMPA receptor antagonist | 0.062 0.024 CID_104607 0.125 0.008 CID_1527023 | CID_1527023 | |
| 0.029 | 0.024 | 0.114 | Somatostatin agonist | 0.114 0.007 CID_104607 | CID_104607 | |
| 0.018 | 0.014 | 0.018 | Cathepsin S inhibitor | |||
| 0.013 | 0.009 | 0.018 | DNA polymerase III polC-type inhibitor | 0.018 0.004 CID_1527023 | CID_1527023 | |
| 0.049 | 0.046 | 0.049 | CC chemokine 2 receptor antagonist | |||
| 0.142 | 0.139 | 0.174 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.174 0.1 CID_104607 | CID_104607 | |
| 0.015 | 0.012 | 0.018 | 4-Hydroxyphenylpyruvate dioxygenase inhibitor | 0.015 0.011 CID_158069 0.018 0.005 CID_1527023 | CID_1527023 | |
| 0.025 | 0.023 | 0.062 | 5 Hydroxytryptamine 1D agonist | 0.062 0.007 CID_1527023 | CID_1527023 | |
| 0.018 | 0.015 | 0.024 | Granulocyte colony stimulating factor receptor agonist | 0.019 0.01 CID_104607 0.024 0.005 CID_1527023 | CID_1527023 | |
| 0.034 | 0.032 | 0.039 | ATM kinase inhibitor | 0.039 0.019 CID_104607 | CID_104607 | |
| 0.052 | 0.052 | 0.069 | 5 Hydroxytryptamine 5 antagonist | 0.069 0.027 CID_104607 0.059 0.038 CID_1527023 | CID_104607 | |
| 0.183 | 0.183 | 0.277 | Immunomodulator | 0.277 0.095 CID_1527023 | CID_1527023 | |
| 0.038 | 0.04 | 0.165 | GABA B receptor antagonist | 0.165 0.004 CID_104607 0.045 0.025 CID_1527023 | CID_104607 | |
| 0.023 | 0.025 | 0.078 | AMPA 1 receptor antagonist | 0.042 0.014 CID_104607 0.078 0.007 CID_1527023 | CID_1527023 | |
| 0.052 | 0.055 | 0.148 | Phosphodiesterase 1B inhibitor | 0.148 0.007 CID_1527023 | CID_1527023 | |
| 0.029 | 0.032 | 0.039 | Purinergic P2Y2 antagonist | 0.039 0.017 CID_1527023 | CID_1527023 | |
| 0.041 | 0.046 | 0.263 | Adenosine A2b receptor antagonist | 0.263 0.004 CID_1527023 | CID_1527023 | |
| 0.019 | 0.025 | 0.044 | Kainate receptor 4 antagonist | 0.024 0.018 CID_104607 0.044 0.008 CID_1527023 | CID_1527023 | |
| 0.029 | 0.036 | 0.056 | NMDA receptor subunit 3A antagonist | 0.04 0.025 CID_104607 0.056 0.018 CID_158069 0.037 0.028 CID_1527023 | CID_158069 | |
| 0.053 | 0.061 | 0.124 | Phosphodiesterase 1A inhibitor | 0.064 0.033 CID_104607 0.124 0.006 CID_1527023 | CID_1527023 | |
| 0.051 | 0.059 | 0.084 | Pregnane X receptor antagonist | 0.056 0.041 CID_104607 0.084 0.005 CID_1527023 | CID_1527023 | |
| 0.045 | 0.053 | 0.225 | GABA receptor antagonist | 0.225 0.005 CID_104607 0.054 0.038 CID_1527023 | CID_104607 | |
| 0.125 | 0.134 | 0.138 | Antipruritic | 0.138 0.109 CID_104607 0.13 0.122 CID_1527023 | CID_104607 | |
| 0.157 | 0.167 | 0.3 | Cardiotonic | 0.3 0.056 CID_1527023 | CID_1527023 | |
| 0.063 | 0.073 | 0.191 | Adenosine A3 receptor antagonist | 0.191 0.01 CID_1527023 | CID_1527023 | |
| 0.075 | 0.086 | 0.103 | CC chemokine 5 receptor agonist | 0.103 0.018 CID_1527023 | CID_1527023 | |
| 0.007 | 0.018 | 0.01 | CXC chemokine 3 receptor agonist | 0.01 0.007 CID_1527023 | CID_1527023 | |
| 0.035 | 0.048 | 0.063 | Chemokine receptor agonist | 0.063 0.025 CID_1527023 | CID_1527023 | |
| 0.013 | 0.027 | 0.029 | Kainate receptor 5 antagonist | 0.029 0.01 CID_1527023 | CID_1527023 | |
| 0.066 | 0.08 | 0.089 | Cell adhesion molecule inhibitor | 0.089 0.044 CID_104607 | CID_104607 | |
| 0.064 | 0.078 | 0.098 | Phosphodiesterase VI inhibitor | 0.098 0.021 CID_1527023 | CID_1527023 | |
| 0.126 | 0.141 | 0.157 | Ca2+-transporting ATPase inhibitor | 0.157 0.028 CID_1527023 | CID_1527023 | |
| 0.031 | 0.046 | 0.038 | Nicotinic acid receptor 1 agonist | 0.038 0.031 CID_1527023 | CID_1527023 | |
| 0.127 | 0.144 | 0.159 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.159 0.104 CID_104607 | CID_104607 | |
| 0.018 | 0.035 | 0.032 | Poly(ADP-ribose) polymerase 2 inhibitor | 0.031 0.017 CID_104607 0.032 0.016 CID_1527023 | CID_1527023 | |
| 0.032 | 0.049 | 0.069 | AMPA 4 receptor antagonist | 0.038 0.03 CID_104607 0.069 0.008 CID_1527023 | CID_1527023 | |
| 0.011 | 0.029 | 0.022 | Kainate receptor 3 antagonist | 0.022 0.008 CID_1527023 | CID_1527023 | |
| 0.035 | 0.059 | 0.091 | Glutamate (mGluR group III) antagonist | 0.091 0.006 CID_1527023 | CID_1527023 | |
| 0.038 | 0.062 | 0.084 | Histamine H4 receptor antagonist | 0.084 0.007 CID_104607 | CID_104607 | |
| 0.054 | 0.079 | 0.103 | Benzodiazepine agonist | 0.103 0.024 CID_104607 0.066 0.057 CID_1527023 | CID_104607 | |
| 0.024 | 0.05 | 0.031 | DNA topoisomerase IV inhibitor | 0.031 0.017 CID_104607 | CID_104607 | |
| 0.036 | 0.062 | 0.113 | 5 Hydroxytryptamine 2 agonist | 0.113 0.007 CID_104607 | CID_104607 | |
| 0.171 | 0.198 | 0.387 | Tyrosine 3 hydroxylase inhibitor | 0.226 0.094 CID_104607 0.202 0.132 CID_158069 0.387 0.01 CID_1527023 | CID_1527023 | |
| 0.027 | 0.055 | 0.068 | Somatostatin 4 agonist | 0.068 0.01 CID_104607 | CID_104607 | |
| 0.043 | 0.072 | 0.057 | p38 MAP kinase inhibitor | 0.057 0.054 CID_104607 | CID_104607 | |
| 0.031 | 0.06 | 0.043 | Nicotinic receptor alpha3 subunit antagonist | 0.043 0.031 CID_104607 | CID_104607 | |
| 0.015 | 0.045 | 0.024 | Glutaminyl-peptide cyclotransferase inhibitor | 0.024 0.012 CID_1527023 | CID_1527023 | |
| 0.167 | 0.199 | 0.325 | Gastrin inhibitor | 0.191 0.162 CID_104607 0.325 0.019 CID_1527023 | CID_1527023 | |
| 0.02 | 0.054 | 0.035 | Phosphodiesterase 6B inhibitor | 0.035 0.015 CID_1527023 | CID_1527023 | |
| 0.036 | 0.07 | 0.166 | GABA A receptor antagonist | 0.166 0.007 CID_104607 0.048 0.043 CID_1527023 | CID_104607 | |
| 0.187 | 0.221 | 0.211 | Ca(v)3.3 blocker | 0.211 0.169 CID_1527023 | CID_1527023 | |
| 0.047 | 0.082 | 0.087 | MAP kinase 11 inhibitor | 0.087 0.044 CID_104607 | CID_104607 | |
| 0.013 | 0.05 | 0.035 | CXC chemokine receptor agonist | 0.035 0.023 CID_1527023 | CID_1527023 | |
| 0.077 | 0.116 | 0.125 | AMP-activated protein kinase stimulant | 0.125 0.044 CID_104607 0.091 0.084 CID_158069 0.102 0.067 CID_1527023 | CID_104607 | |
| 0.034 | 0.073 | 0.052 | Neuropeptide Y5 antagonist | 0.052 0.035 CID_104607 | CID_104607 | |
| 0.017 | 0.057 | 0.031 | Potassium channel small-conductance Ca-activated activator | 0.031 0.022 CID_1527023 | CID_1527023 | |
| 0.039 | 0.079 | 0.09 | 5 Hydroxytryptamine 2A agonist | 0.09 0.02 CID_104607 | CID_104607 | |
| 0.038 | 0.08 | 0.05 | Phosphodiesterase 6C inhibitor | 0.05 0.022 CID_1527023 | CID_1527023 | |
| 0.049 | 0.093 | 0.101 | Phosphodiesterase 1C inhibitor | 0.06 0.049 CID_104607 0.101 0.01 CID_1527023 | CID_1527023 | |
| 0.023 | 0.068 | 0.037 | DNA gyrase subunit B inhibitor | 0.037 0.027 CID_1527023 | CID_1527023 | |
| 0.049 | 0.094 | 0.168 | Interferon inducer | 0.168 0.004 CID_1527023 | CID_1527023 | |
| 0.015 | 0.061 | 0.023 | Phosphodiesterase 6H inhibitor | 0.023 0.019 CID_1527023 | CID_1527023 | |
| 0.015 | 0.061 | 0.023 | Phosphodiesterase 6G inhibitor | 0.023 0.019 CID_1527023 | CID_1527023 | |
| 0.09 | 0.136 | 0.153 | Nav1.6 sodium channel blocker | 0.153 0.051 CID_1527023 | CID_1527023 | |
| 0.033 | 0.08 | 0.074 | Nicotinic neuronal receptor agonist | 0.074 0.025 CID_104607 | CID_104607 | |
| 0.017 | 0.065 | 0.047 | Acid ceramidase inhibitor | 0.047 0.004 CID_1527023 | CID_1527023 | |
| 0.113 | 0.161 | 0.252 | Anesthetic general | 0.252 0.049 CID_1527023 | CID_1527023 | |
| 0.056 | 0.106 | 0.231 | Interferon agonist | 0.231 0.005 CID_1527023 | CID_1527023 | |
| 0.059 | 0.111 | 0.083 | Antineoplastic alkaloid | 0.083 0.062 CID_158069 | CID_158069 | |
| 0.051 | 0.104 | 0.065 | Beta 2 adrenoreceptor agonist | 0.063 0.038 CID_158069 0.065 0.03 CID_1527023 | CID_1527023 | |
| 0.018 | 0.071 | 0.032 | 5 Hydroxytryptamine 6 agonist | 0.032 0.014 CID_104607 | CID_104607 | |
| 0.027 | 0.081 | 0.051 | Phenylethanolamine N methyltransferase inhibitor | 0.051 0.014 CID_104607 | CID_104607 | |
| 0.046 | 0.1 | 0.088 | Protein kinase B alpha inhibitor | 0.088 0.036 CID_104607 | CID_104607 | |
| 0.028 | 0.086 | 0.221 | Adenosine A1 receptor antagonist | 0.221 0.01 CID_1527023 | CID_1527023 | |
| 0.009 | 0.07 | 0.034 | NMDA receptor glycine site antagonist | 0.034 0.01 CID_104607 | CID_104607 | |
| 0.011 | 0.072 | 0.024 | Dopamine D1 agonist | 0.024 0.014 CID_1527023 | CID_1527023 | |
| 0.041 | 0.102 | 0.06 | DNA gyrase inhibitor | 0.06 0.049 CID_104607 | CID_104607 | |
| 0.032 | 0.095 | 0.1 | NMDA receptor glycine site agonist | 0.1 0.017 CID_104607 0.067 0.039 CID_1527023 | CID_104607 | |
| 0.033 | 0.096 | 0.066 | Myc inhibitor | 0.066 0.022 CID_104607 0.055 0.037 CID_1527023 | CID_104607 | |
| 0.015 | 0.078 | 0.024 | Phosphodiesterase 6A inhibitor | 0.024 0.016 CID_1527023 | CID_1527023 | |
| 0.026 | 0.091 | 0.052 | Dopamine transporter inhibitor | 0.052 0.03 CID_104607 | CID_104607 | |
| 0.041 | 0.107 | 0.116 | Phosphodiesterase V inhibitor | 0.116 0.02 CID_1527023 | CID_1527023 | |
| 0.023 | 0.091 | 0.049 | NMDA receptor subunit 3B antagonist | 0.049 0.026 CID_104607 | CID_104607 | |
| 0.041 | 0.108 | 0.117 | Phosphodiesterase 5A inhibitor | 0.117 0.02 CID_1527023 | CID_1527023 | |
| 0.038 | 0.108 | 0.057 | 5 Hydroxytryptamine 7 agonist | 0.057 0.036 CID_1527023 | CID_1527023 | |
| 0.05 | 0.122 | 0.09 | Prolactin release inhibitor | 0.09 0.006 CID_1527023 | CID_1527023 | |
| 0.085 | 0.159 | 0.189 | Cytidine deaminase inhibitor | 0.189 0.053 CID_1527023 | CID_1527023 | |
| 0.07 | 0.143 | 0.11 | Protein kinase C gamma inhibitor | 0.097 0.081 CID_104607 0.11 0.062 CID_1527023 | CID_1527023 | |
| 0.136 | 0.211 | 0.392 | 5 Hydroxytryptamine release stimulant | 0.372 0.052 CID_104607 0.392 0.047 CID_1527023 | CID_1527023 | |
| 0.065 | 0.141 | 0.129 | Adenylate cyclase inhibitor | 0.1 0.084 CID_104607 0.129 0.06 CID_1527023 | CID_1527023 | |
| 0.014 | 0.09 | 0.148 | 5 Hydroxytryptamine 2C agonist | 0.148 0.005 CID_104607 | CID_104607 | |
| 0.038 | 0.116 | 0.094 | NMDA receptor agonist | 0.094 0.021 CID_104607 0.061 0.045 CID_1527023 | CID_104607 | |
| 0.077 | 0.157 | 0.112 | Acetylcholine release stimulant | 0.112 0.062 CID_1527023 | CID_1527023 | |
| 0.019 | 0.102 | 0.06 | Dopamine D5 agonist | 0.038 0.031 CID_104607 0.06 0.012 CID_1527023 | CID_1527023 | |
| 0.029 | 0.113 | 0.045 | Alpha 1L adrenoreceptor agonist | 0.045 0.024 CID_104607 | CID_104607 | |
| 0.04 | 0.124 | 0.071 | Nav1.8 sodium channel blocker | 0.071 0.055 CID_104607 | CID_104607 | |
| 0.034 | 0.12 | 0.052 | Nicotinic alpha3beta2 receptor antagonist | 0.052 0.039 CID_104607 0.051 0.04 CID_1527023 | CID_104607 | |
| 0.155 | 0.243 | 0.282 | Antithrombotic | 0.282 0.101 CID_1527023 | CID_1527023 | |
| 0.039 | 0.128 | 0.106 | Cathepsin G inhibitor | 0.106 0.031 CID_1527023 | CID_1527023 | |
| 0.029 | 0.118 | 0.054 | Nicotinic receptor alpha4 subunit antagonist | 0.054 0.027 CID_104607 | CID_104607 | |
| 0.006 | 0.095 | 0.027 | Nicotinic alpha4 receptor agonist | 0.027 0.005 CID_104607 | CID_104607 | |
| 0.023 | 0.116 | 0.078 | 5 Hydroxytryptamine 2B agonist | 0.078 0.005 CID_104607 | CID_104607 | |
| 0.118 | 0.212 | 0.342 | Vasodilator | 0.342 0.035 CID_1527023 | CID_1527023 | |
| 0.031 | 0.124 | 0.092 | Alpha 2 adrenoreceptor agonist | 0.077 0.026 CID_104607 0.092 0.018 CID_1527023 | CID_1527023 | |
| 0.078 | 0.171 | 0.18 | Interleukin 4 antagonist | 0.126 0.077 CID_158069 0.18 0.03 CID_1527023 | CID_1527023 | |
| 0.026 | 0.12 | 0.056 | Kainate receptor agonist | 0.056 0.009 CID_1527023 | CID_1527023 | |
| 0.052 | 0.147 | 0.161 | Mediator release inhibitor | 0.161 0.024 CID_1527023 | CID_1527023 | |
| 0.145 | 0.241 | 0.203 | 5 Hydroxytryptamine 3E antagonist | 0.169 0.138 CID_104607 0.203 0.057 CID_1527023 | CID_1527023 | |
| 0.057 | 0.153 | 0.111 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.111 0.045 CID_104607 0.106 0.049 CID_1527023 | CID_104607 | |
| 0.03 | 0.127 | 0.125 | Phosphodiesterase III inhibitor | 0.125 0.014 CID_1527023 | CID_1527023 | |
| 0.146 | 0.246 | 0.388 | Vasodilator, coronary | 0.388 0.039 CID_1527023 | CID_1527023 | |
| 0.101 | 0.201 | 0.15 | Pregnane X receptor agonist | 0.128 0.105 CID_104607 0.15 0.052 CID_1527023 | CID_1527023 | |
| 0.091 | 0.193 | 0.183 | Polo-like kinase-3 inhibitor | 0.183 0.055 CID_104607 | CID_104607 | |
| 0.027 | 0.128 | 0.204 | Adenosine A2 receptor antagonist | 0.204 0.01 CID_1527023 | CID_1527023 | |
| 0.057 | 0.159 | 0.128 | NADH dehydrogenase inhibitor | 0.084 0.066 CID_104607 0.128 0.025 CID_1527023 | CID_1527023 | |
| 0.045 | 0.15 | 0.101 | Glycine receptor antagonist | 0.085 0.049 CID_104607 0.101 0.031 CID_1527023 | CID_1527023 | |
| 0.042 | 0.147 | 0.081 | Potassium channel (Ca-activated) activator | 0.081 0.074 CID_104607 0.078 0.077 CID_1527023 | CID_104607 | |
| 0.009 | 0.116 | 0.031 | AMPA 3 receptor antagonist | 0.031 0.02 CID_1527023 | CID_1527023 | |
| 0.084 | 0.194 | 0.179 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | 0.179 0.076 CID_104607 | CID_104607 | |
| 0.018 | 0.128 | 0.048 | Delayed rectifier potassium channel blocker | 0.048 0.013 CID_1527023 | CID_1527023 | |
| 0.141 | 0.252 | 0.19 | Nootropic | 0.19 0.172 CID_104607 | CID_104607 | |
| 0.023 | 0.134 | 0.05 | Histamine H1 receptor agonist | 0.05 0.018 CID_1527023 | CID_1527023 | |
| 0.059 | 0.172 | 0.116 | Electrolyte absorption antagonist | 0.116 0.04 CID_104607 0.109 0.047 CID_1527023 | CID_104607 | |
| 0.021 | 0.134 | 0.073 | Cannabinoid CB1 receptor agonist | 0.073 0.033 CID_1527023 | CID_1527023 | |
| 0.08 | 0.196 | 0.102 | Interleukin 2 antagonist | 0.102 0.084 CID_104607 | CID_104607 | |
| 0.123 | 0.24 | 0.383 | Superoxide dismutase inhibitor | 0.165 0.162 CID_104607 0.383 0.03 CID_1527023 | CID_1527023 | |
| 0.156 | 0.276 | 0.506 | GABA C receptor rho-3 antagonist | 0.274 0.134 CID_104607 0.506 0.024 CID_1527023 | CID_1527023 | |
| 0.036 | 0.157 | 0.074 | Acetylcholine nicotinic antagonist | 0.074 0.061 CID_104607 | CID_104607 | |
| 0.03 | 0.151 | 0.123 | Glutamate receptor agonist | 0.123 0.025 CID_1527023 | CID_1527023 | |
| 0.099 | 0.224 | 0.151 | Platelet antagonist | 0.151 0.143 CID_104607 | CID_104607 | |
| 0.058 | 0.188 | 0.143 | Ribosomal protein S6 kinase inhibitor | 0.143 0.07 CID_104607 | CID_104607 | |
| 0.024 | 0.154 | 0.061 | Cyclin-dependent kinase 6 inhibitor | 0.061 0.04 CID_104607 | CID_104607 | |
| 0.012 | 0.144 | 0.039 | Epoxide hydrolase 1 inhibitor | 0.039 0.012 CID_1527023 | CID_1527023 | |
| 0.026 | 0.159 | 0.067 | Neuronal nicotinic receptor antagonist | 0.067 0.047 CID_104607 | CID_104607 | |
| 0.029 | 0.164 | 0.065 | Protein kinase C beta inhibitor | 0.065 0.059 CID_1527023 | CID_1527023 | |
| 0.011 | 0.147 | 0.045 | Peptide deformylase inhibitor | 0.045 0.012 CID_1527023 | CID_1527023 | |
| 0.151 | 0.288 | 0.333 | 5 Hydroxytryptamine uptake stimulant | 0.333 0.031 CID_104607 0.257 0.074 CID_1527023 | CID_104607 | |
| 0.022 | 0.163 | 0.06 | TRPA1 antagonist | 0.06 0.043 CID_1527023 | CID_1527023 | |
| 0.02 | 0.161 | 0.076 | Cannabinoid receptor agonist | 0.076 0.037 CID_1527023 | CID_1527023 | |
| 0.045 | 0.189 | 0.198 | Prolactin inhibitor | 0.198 0.009 CID_1527023 | CID_1527023 | |
| 0.145 | 0.291 | 0.202 | Caspase 3 stimulant | 0.202 0.166 CID_158069 | CID_158069 | |
| 0.007 | 0.154 | 0.039 | Nicotinic alpha4beta2 receptor agonist | 0.039 0.009 CID_104607 | CID_104607 | |
| 0.108 | 0.257 | 0.215 | DNA damaging | 0.215 0.104 CID_1527023 | CID_1527023 | |
| 0.007 | 0.159 | 0.039 | Nicotinic alpha3beta4 receptor agonist | 0.039 0.011 CID_104607 | CID_104607 | |
| 0.091 | 0.245 | 0.158 | Sphingosine 1-phosphate receptor 5 antagonist | 0.158 0.048 CID_1527023 | CID_1527023 | |
| 0.043 | 0.197 | 0.184 | Bronchodilator | 0.184 0.021 CID_1527023 | CID_1527023 | |
| 0.015 | 0.17 | 0.162 | Adenosine A2a receptor antagonist | 0.162 0.014 CID_1527023 | CID_1527023 | |
| 0.033 | 0.193 | 0.094 | ALK inhibitor | 0.094 0.045 CID_104607 | CID_104607 | |
| 0.124 | 0.284 | 0.161 | ErbB-1 antagonist | 0.161 0.151 CID_158069 | CID_158069 | |
| 0.022 | 0.187 | 0.056 | Purinergic P2X4 antagonist | 0.056 0.017 CID_104607 | CID_104607 | |
| 0.106 | 0.275 | 0.287 | Beta lactamase inhibitor | 0.287 0.14 CID_1527023 | CID_1527023 | |
| 0.02 | 0.189 | 0.082 | Carbamoyl phosphate synthetase inhibitor | 0.082 0.028 CID_1527023 | CID_1527023 | |
| 0.079 | 0.251 | 0.14 | DNA methylase inhibitor | 0.14 0.126 CID_1527023 | CID_1527023 | |
| 0.085 | 0.26 | 0.141 | Interferon gamma antagonist | 0.141 0.09 CID_1527023 | CID_1527023 | |
| 0.083 | 0.258 | 0.256 | Immunostimulant | 0.256 0.094 CID_1527023 | CID_1527023 | |
| 0.008 | 0.185 | 0.046 | Glutamate (mGluR2) agonist | 0.046 0.015 CID_1527023 | CID_1527023 | |
| 0.01 | 0.188 | 0.026 | Toll-Like receptor 8 agonist | 0.026 0.006 CID_1527023 | CID_1527023 | |
| 0.166 | 0.346 | 0.235 | MAP kinase kinase 6 inhibitor | 0.235 0.21 CID_104607 | CID_104607 | |
| 0.051 | 0.231 | 0.123 | Phosphodiesterase inhibitor | 0.123 0.079 CID_1527023 | CID_1527023 | |
| 0.038 | 0.219 | 0.091 | Glycine receptor agonist | 0.091 0.027 CID_1527023 | CID_1527023 | |
| 0.01 | 0.192 | 0.049 | Glutamate (mGluR group II) agonist | 0.049 0.016 CID_1527023 | CID_1527023 | |
| 0.141 | 0.324 | 0.319 | Calcium channel activator | 0.319 0.074 CID_1527023 | CID_1527023 | |
| 0.033 | 0.219 | 0.092 | Myeloperoxidase inhibitor | 0.092 0.045 CID_1527023 | CID_1527023 | |
| 0.072 | 0.258 | 0.13 | DNA methyltransferase I inhibitor | 0.13 0.129 CID_1527023 | CID_1527023 | |
| 0.013 | 0.204 | 0.041 | CDK5/p25 inhibitor | 0.041 0.028 CID_1527023 | CID_1527023 | |
| 0.047 | 0.239 | 0.086 | Lanosterol 14 alpha demethylase inhibitor | 0.086 0.079 CID_104607 0.085 0.082 CID_1527023 | CID_104607 | |
| 0.011 | 0.204 | 0.06 | Cannabinoid CB2 receptor agonist | 0.06 0.034 CID_1527023 | CID_1527023 | |
| 0.099 | 0.293 | 0.149 | Neurotensin receptor agonist | 0.142 0.122 CID_104607 0.149 0.103 CID_1527023 | CID_1527023 | |
| 0.055 | 0.249 | 0.101 | Nav1.5 sodium channel blocker | 0.101 0.084 CID_104607 | CID_104607 | |
| 0.087 | 0.285 | 0.149 | Neurotrophic factor enhancer | 0.149 0.14 CID_1527023 | CID_1527023 | |
| 0.02 | 0.224 | 0.058 | Androgen agonist | 0.058 0.043 CID_104607 | CID_104607 | |
| 0.021 | 0.225 | 0.076 | Check point kinase 1 inhibitor | 0.076 0.041 CID_104607 | CID_104607 | |
| 0.152 | 0.357 | 0.221 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.221 0.113 CID_104607 | CID_104607 | |
| 0.021 | 0.227 | 0.05 | Dopamine beta hydroxylase inhibitor | 0.05 0.031 CID_1527023 | CID_1527023 | |
| 0.02 | 0.23 | 0.094 | Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | 0.094 0.039 CID_104607 | CID_104607 | |
| 0.016 | 0.226 | 0.05 | Nicotinic receptor alpha7 subunit antagonist | 0.05 0.043 CID_104607 | CID_104607 | |
| 0.093 | 0.304 | 0.19 | Thioredoxin glutathione reductase inhibitor | 0.19 0.181 CID_1527023 | CID_1527023 | |
| 0.005 | 0.22 | 0.032 | Uridine phosphorylase inhibitor | 0.032 0.016 CID_1527023 | CID_1527023 | |
| 0.034 | 0.259 | 0.156 | Creatine kinase inhibitor | 0.156 0.022 CID_1527023 | CID_1527023 | |
| 0.103 | 0.338 | 0.337 | DNA directed DNA polymerase inhibitor | 0.337 0.144 CID_1527023 | CID_1527023 | |
| 0.035 | 0.276 | 0.085 | HIV-1 integrase (Overall Integration) inhibitor | 0.085 0.071 CID_104607 | CID_104607 | |
| 0.035 | 0.277 | 0.137 | GABA C receptor agonist | 0.133 0.041 CID_104607 0.137 0.04 CID_1527023 | CID_1527023 | |
| 0.034 | 0.283 | 0.129 | UDP-glucose 4-epimerase inhibitor | 0.129 0.038 CID_1527023 | CID_1527023 | |
| 0.07 | 0.325 | 0.137 | Tumour necrosis factor antagonist | 0.137 0.117 CID_1527023 | CID_1527023 | |
| 0.012 | 0.268 | 0.066 | Adenosine deaminase inhibitor | 0.066 0.016 CID_1527023 | CID_1527023 | |
| 0.081 | 0.337 | 0.262 | Thyroid hormone beta antagonist | 0.262 0.111 CID_1527023 | CID_1527023 | |
| 0.056 | 0.317 | 0.162 | Cyclin-dependent kinase 8 inhibitor | 0.162 0.068 CID_104607 | CID_104607 | |
| 0.019 | 0.283 | 0.102 | Anesthetic local | 0.102 0.081 CID_1527023 | CID_1527023 | |
| 0.008 | 0.273 | 0.04 | Nicotinic acid receptor agonist | 0.04 0.021 CID_1527023 | CID_1527023 | |
| 0.09 | 0.356 | 0.166 | MAP-kinase-activated kinase 5 inhibitor | 0.166 0.155 CID_104607 | CID_104607 | |
| 0.054 | 0.327 | 0.231 | MAP kinase kinase 2 inhibitor | 0.137 0.133 CID_104607 0.231 0.064 CID_1527023 | CID_1527023 | |
| 0.043 | 0.326 | 0.138 | Antibacterial (Helicobacter pylori) | 0.138 0.058 CID_1527023 | CID_1527023 | |
| 0.074 | 0.36 | 0.266 | Thyroid hormone antagonist | 0.266 0.113 CID_1527023 | CID_1527023 | |
| 0.011 | 0.298 | 0.074 | Argininosuccinate synthase inhibitor | 0.074 0.028 CID_1527023 | CID_1527023 | |
| 0.02 | 0.308 | 0.045 | Topoisomerase II beta inhibitor | 0.045 0.042 CID_104607 | CID_104607 | |
| 0.082 | 0.372 | 0.144 | Death-associated protein kinase 2 inhibitor | 0.144 0.12 CID_1527023 | CID_1527023 | |
| 0.033 | 0.338 | 0.133 | GABA C receptor rho-1 antagonist | 0.102 0.06 CID_104607 0.133 0.03 CID_1527023 | CID_1527023 | |
| 0.098 | 0.407 | 0.143 | Heat shock protein 70 antagonist | 0.143 0.065 CID_1527023 | CID_1527023 | |
| 0.056 | 0.368 | 0.195 | GABA C receptor rho-2 antagonist | 0.195 0.032 CID_1527023 | CID_1527023 | |
| 0.009 | 0.326 | 0.028 | Glutamate (mGluR1) agonist | 0.028 0.012 CID_1527023 | CID_1527023 | |
| 0.08 | 0.399 | 0.293 | Cholesterol antagonist | 0.293 0.096 CID_1527023 | CID_1527023 | |
| 0.011 | 0.331 | 0.101 | Biliverdin reductase inhibitor | 0.101 0.018 CID_1527023 | CID_1527023 | |
| 0.048 | 0.37 | 0.159 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.159 0.132 CID_1527023 | CID_1527023 | |
| 0.059 | 0.383 | 0.174 | Succinate dehydrogenase inhibitor | 0.174 0.075 CID_1527023 | CID_1527023 | |
| 0.006 | 0.34 | 0.045 | Ornithine carbamoyltransferase inhibitor | 0.045 0.044 CID_1527023 | CID_1527023 | |
| 0.032 | 0.375 | 0.144 | Alpha-N-acetylglucosaminidase inhibitor | 0.144 0.059 CID_1527023 | CID_1527023 | |
| 0.014 | 0.359 | 0.082 | Cytokine production stimulant | 0.082 0.005 CID_1527023 | CID_1527023 | |
| 0.041 | 0.387 | 0.123 | MAP3K9 inhibitor | 0.123 0.108 CID_1527023 | CID_1527023 | |
| 0.062 | 0.41 | 0.245 | DNA polymerase beta inhibitor | 0.245 0.195 CID_1527023 | CID_1527023 | |
| 0.024 | 0.373 | 0.062 | Ryanodine receptor antagonist | 0.062 0.031 CID_1527023 | CID_1527023 | |
| 0.121 | 0.472 | 0.327 | 5 Hydroxytryptamine release inhibitor | 0.327 0.136 CID_1527023 | CID_1527023 | |
| 0.012 | 0.363 | 0.058 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.058 0.037 CID_1527023 | CID_1527023 | |
| 0.021 | 0.376 | 0.052 | Glucosylceramidase inhibitor | 0.052 0.044 CID_1527023 | CID_1527023 | |
| 0.097 | 0.453 | 0.167 | Peptidyltransferase inhibitor | 0.167 0.152 CID_1527023 | CID_1527023 | |
| 0.05 | 0.409 | 0.234 | Insulin secretagoues | 0.234 0.023 CID_1527023 | CID_1527023 | |
| 0.053 | 0.414 | 0.14 | Adenylate cyclase stimulant | 0.14 0.08 CID_1527023 | CID_1527023 | |
| 0.024 | 0.389 | 0.258 | Ferrochelatase inhibitor | 0.258 0.012 CID_1527023 | CID_1527023 | |
| 0.012 | 0.378 | 0.096 | Check point kinase 2 inhibitor | 0.096 0.069 CID_104607 | CID_104607 | |
| 0.023 | 0.395 | 0.136 | GABA C receptor antagonist | 0.108 0.067 CID_104607 0.136 0.038 CID_1527023 | CID_1527023 | |
| 0.035 | 0.408 | 0.124 | Cell wall synthesis inhibitor | 0.124 0.094 CID_1527023 | CID_1527023 | |
| 0.015 | 0.392 | 0.081 | Pim-3 kinase inhibitor | 0.081 0.076 CID_104607 | CID_104607 | |
| 0.045 | 0.424 | 0.086 | Glutamate release inhibitor | 0.086 0.073 CID_1527023 | CID_1527023 | |
| 0.029 | 0.409 | 0.087 | Bile acid receptor antagonist | 0.087 0.081 CID_1527023 | CID_1527023 | |
| 0.045 | 0.452 | 0.25 | Alpha-glucosidase inhibitor | 0.25 0.188 CID_1527023 | CID_1527023 | |
| 0.021 | 0.432 | 0.068 | Glutamate dehydrogenase inhibitor | 0.068 0.059 CID_1527023 | CID_1527023 | |
| 0.055 | 0.479 | 0.147 | Histone acetyltransferase inhibitor | 0.147 0.144 CID_1527023 | CID_1527023 | |
| 0.014 | 0.44 | 0.106 | Alcohol dehydrogenase inhibitor | 0.106 0.047 CID_1527023 | CID_1527023 | |
| 0.042 | 0.468 | 0.103 | Transcription factor STAT6 inhibitor | 0.103 0.099 CID_1527023 | CID_1527023 | |
| 0.04 | 0.475 | 0.189 | Interleukin agonist | 0.189 0.131 CID_1527023 | CID_1527023 | |
| 0.025 | 0.471 | 0.081 | Triose-phosphate isomerase inhibitor | 0.081 0.074 CID_1527023 | CID_1527023 | |
| 0.027 | 0.489 | 0.097 | Granulocyte macrophage colony stimulating factor agonist | 0.097 0.039 CID_1527023 | CID_1527023 | |
| 0.032 | 0.496 | 0.224 | Peroxidase inhibitor | 0.224 0.053 CID_1527023 | CID_1527023 | |
| 0.041 | 0.509 | 0.232 | Calpain 2 inhibitor | 0.232 0.162 CID_1527023 | CID_1527023 | |
| 0.001 | 0.479 | 0.012 | Angiotensin AT1B receptor antagonist | 0.012 0.011 CID_1527023 | CID_1527023 | |
| 0.006 | 0.494 | 0.069 | Alcohol oxidase inhibitor | 0.069 0.029 CID_1527023 | CID_1527023 | |
| 0.07 | 0.559 | 0.255 | MAP kinase 1 inhibitor | 0.255 0.227 CID_1527023 | CID_1527023 | |
| 0.015 | 0.526 | 0.089 | Gastric antisecretory | 0.089 0.08 CID_1527023 | CID_1527023 | |
| 0.033 | 0.549 | 0.124 | Adenylate kinase inhibitor | 0.124 0.04 CID_1527023 | CID_1527023 | |
| 0.005 | 0.522 | 0.055 | Acyl-CoA dehydrogenase inhibitor | 0.055 0.037 CID_1527023 | CID_1527023 | |
| 0.053 | 0.584 | 0.196 | Insulysin inhibitor | 0.196 0.163 CID_1527023 | CID_1527023 | |
| 0.007 | 0.56 | 0.073 | Porphobilinogen synthase inhibitor | 0.073 0.053 CID_1527023 | CID_1527023 | |
| 0.017 | 0.592 | 0.108 | Toll-Like receptor 2 antagonist | 0.108 0.092 CID_1527023 | CID_1527023 | |
| 0.003 | 0.579 | 0.049 | Angiotensin AT1 receptor antagonist | 0.049 0.019 CID_1527023 | CID_1527023 | |
| 0.031 | 0.609 | 0.169 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.169 0.11 CID_1527023 | CID_1527023 | |
| 0.003 | 0.581 | 0.049 | Geranyltranstransferase inhibitor | 0.049 0.024 CID_1527023 | CID_1527023 | |
| 0.024 | 0.608 | 0.111 | Photosensitizer | 0.111 0.07 CID_1527023 | CID_1527023 | |
| 0.004 | 0.588 | 0.035 | Angiotensin II receptor antagonist | 0.035 0.022 CID_1527023 | CID_1527023 | |
| 0.033 | 0.629 | 0.161 | CF transmembrane conductance regulator agonist | 0.161 0.058 CID_1527023 | CID_1527023 | |
| 0.086 | 0.705 | 0.266 | Calcium channel L-type activator | 0.266 0.188 CID_1527023 | CID_1527023 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |